Prostate Cancer

PCaGuard: A Software Platform to Support Optimal Management of Prostate Cancer. January 21, 2022

Endogenous testosterone density is an independent predictor of pelvic lymph node invasion in high-risk prostate cancer: results in 201 consecutive patients treated with radical prostatectomy and extended pelvic lymph node dissection. January 21, 2022

Active surveillance for intermediate-risk prostate cancer. January 21, 2022

Transrectal Ultrasound-Guided Biopsy Should Continue to Be a Standard of Care for The Detection of Prostate Cancer. January 21, 2022

Prostate-Specific Antigen Screening According to Health Professional Counseling and Age in the United States. January 21, 2022

MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer. January 20, 2022

Supportive care needs of men with prostate cancer: A systematic review update. January 20, 2022

Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System. January 20, 2022

Real-world evidence of patients with metastatic castration-resistant prostate cancer treated with cabazitaxel: comparison with the randomized clinical study CARD. January 20, 2022

Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone-sensitive prostate cancer with Gleason score ≥8. January 20, 2022

Examination of prostate-specific antigen (PSA) screening in military and civilian men: analysis of the 2018 behavioral risk factor surveillance system. January 19, 2022

Value of T2 Mapping MRI for Prostate Cancer Detection and Classification. January 19, 2022

Diagnostic performance of fusion (US/MRI guided) prostate biopsy: propensity score matched comparison of elastic versus rigid fusion system. January 19, 2022

A Phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer. January 19, 2022

Changes in Magnetic Resonance Imaging Radiomic Features in Response to Androgen Deprivation Therapy in Patients with Intermediate- and High-risk Prostate Cancer. January 19, 2022

Androgen Deprivation Therapy Use and Duration with Definitive Radiotherapy for Localised Prostate Cancer: An Individual Patient Data Meta-Analysis January 18, 2022

Sequencing of Systemic Therapies in the Management of Advanced Prostate Cancer in India: a Delphi-Based Consensus. January 18, 2022

Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consorti January 18, 2022

Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy-implications on clinically-significant prostate cancer detection and relevance to focal therapy planning. January 18, 2022

Risk-based MRI-directed diagnostic pathway outperforms non-risk-based pathways in suspected prostate cancer biopsy-naïve men: a large cohort validation study. January 18, 2022

Page 1 of 1199

email news signup